Clinical Trials for Hormone Receptor(HR)-Positive, Low HER2 Advanced Breast Cancer Patients (HER2 IHC 1+ or 2+ & ISH Negative)

Find clinical trials for hormone receptor(hr)-positive, low her2 advanced breast cancer patients (her2 ihc 1+ or 2+ & ish negative). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer

NCT ID: NCT06837792

This clinical trial is looking at a new treatment called Trastuzumab Deruxtecan (often shortened to T-DXd) for women with advanced breast cancer that is hormone receptor-positive and has low levels...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions